期刊文献+

匹多莫德体外抑制弓形虫增殖作用的研究 被引量:5

In vitro effects of Pidotimod on the proliferation of Toxoplasma gondii
原文传递
导出
摘要 目的评价匹多莫德对体外细胞培养弓形虫的抑制作用。方法在96孔板中采用Hela细胞培养稳定表达绿色荧光蛋白的弓形虫RH株速殖子,实验设匹多莫德用药组、磺胺甲恶唑(SMX)用药组、SMX+匹多莫德联合用药组以及未用药对照组,观察比较绿色荧光弓形虫速殖子给药后48、72、96h和120h的增殖情况及活虫数。结果与未用药组比较,SMX1mg/ml(P<0.01)、0.5mg/ml(P<0.01)和0.25mg/ml(P<0.01)剂量组在各时间点均可显著抑制弓形虫速殖子的增殖;匹多莫德25μg/ml(P<0.05)、12.5μg/ml(P<0.05)和6.25μg/ml(P<0.05)剂量组均可一定程度地抑制弓形虫速殖子的增殖;SMX(0.25mg/ml)+匹多莫德(25μg/ml)活虫数最低,与SMX1mg/ml单独使用对弓形虫速殖子的抑制作用相近(P=0.311)。结论匹多莫德具有一定的体外抑制弓形虫速殖子增殖的作用;匹多莫德与SMX联合应用既能降低SMX用量又能有效抑虫。 Objective To evaluate the in vitro effect of Pidotimod on the proliferation of Toxoplasma gondii. Methods The green fluorescent protein (GFP)-expressing RH tachyzoites of T. gondii were cultured in Hela cells. The cells were divided into the Pidotimod-treated, SMX-treated, SMX+Pidotimod-treated and untreated control groups. The morphology and the proliferation of the tachyzoites were determined, and the fluorescence values were analyzed. The numbers of live tachyzoites were enumerated at 48,72,96,and 120 h post-treatment. Results Compared with the untreated control, SMX (0.25-1 mg/ml) significantly inhibited the proliferation of tachyzoites at a 48-120 h after the treatment (P〈0.01). Pidotimod (6.25-25 μg/ml) also inhibited the proliferation of tachyzoites (P〈0.05). The inhibitory effect of combined SMX (0.25 mg/ml) and Pidotimod (25μg/ml) treatment was similar to the single treatment with SMX (1 mg/ml,P= 0.311 ). Conclusion Pidotimod is effective in inhibiting the proliferation of T. gondii and the combination of Pidotimod with SMX may help to reduce the dosage of SMX.
作者 赵莹 吕芳丽
出处 《热带医学杂志》 CAS 2013年第5期531-534,623,共5页 Journal of Tropical Medicine
基金 国家重点基础研究发展规划"973"项目(2010CB530001) 国家自然科学基金(81071387 81271854) 广东省自然科学基金(10151008901000006)
关键词 弓形虫 体外 匹多莫德 Toxoplasma gondii in vitro Pidotimod
  • 相关文献

参考文献16

  • 1Frenkel JK.Pathophysiology of toxoplasmosis [J].Parasitol Today, 1988,4 (10) : 273-278.
  • 2Leport C,Chene G,Morlat P,et al.Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection : a double-blind, randomized trial[J].J Infect Dis, 1996, 173( 1 ) :91-97.
  • 3Norose K, Aosai F, Mun HS, et al.Effects of sulfamethoxazole on mufine ocular toxoplasmosis in interferon knockout mice[J]. Invest Ophthalmol Vis Sci, 2006,47 ( 1 ) : 265-271.
  • 4Aivazis V, Hatzimichail A, Papachristou A, et al.Clinical evaluation and changes of the respiratory epithelium function after administration of Pidotimod in Greek children with recurrent respiratory tract infections [J].Minerva Pediatr, 2002, 54(4) : 315-319.
  • 5La Mantia I,Grillo C,Mattina T,et al.Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome[J].J Chemother, 1999,11 (2) : 126-130.
  • 6Zervoudis S, Iatrakis G, Peitsidis P, et al.Complementary treatment with oral pidotimod plus vitamin C after laser vaporization for female genital warts: a prospective study [J] .J Med Life, 2010,3(3) :286-288.
  • 7赵莹,吕芳丽.匹多莫德在感染性疾病中的应用及实验研究进展[J].热带医学杂志,2012,12(8):1034-1037. 被引量:24
  • 8Di Renzo M,Pasqui AL,Brnni F,et al.The in vitro effect of Pidotimod on some immune functions in cancer patients [J].Immunopharmacol Immunotoxicnl, 1997,19( 1 ) : 37-51.
  • 9Yang X,Huang B,Chen J,et al.ln vitro effects of aqueous extracts of Astragalus membranaceus and Scutellaria baicalensis GEORGI on Toxoplasma gondii [J].Parasitol Res,2012,110 (6) : 2221-2227.
  • 10Iaccheri B,Fiore T,Papadaki T,et al.Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review [ J ].Clin Ther, 2008,30 ( 11 ) : 2069-2074.

二级参考文献81

共引文献122

同被引文献58

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部